Doxycycline vs levofloxacin for macrolide-unresponsive Mycoplasma pneumoniae pneumonia in children: a real-world study from China
Abstract
BACKGROUND: Macrolide-unresponsive Mycoplasma pneumoniae pneumonia (MUMPP) is a growing concern in paediatrics, yet comparative data on second-line antibiotics remain limited. This study aimed to evaluate the efficacy and safety of doxycycline and levofloxacin in treating MUMPP in children. METHODS: This single-centre, real-world observational cohort study was conducted in a tertiary paediatric hospital in China. We included children hospitalised with M. pneumoniae pneumonia between July and December 2023. Patients were classified as having macrolide-sensitive M. pneumoniae pneumonia (MSMPP) or MUMPP according to their clinical response to initial azithromycin therapy. MUMPP patients were further allocated to the doxycycline, levofloxacin, or azithromycin group, based on the second-line antibiotic prescribed. Clinical characteristics, treatment outcomes, and adverse events were compared across groups. The primary outcome measures were the duration of pulmonary signs and the duration of fever after the change of antibiotic. The secondary outcome measure was the incidence of adverse events. RESULTS: MUMPP accounted for 66.6% (365/548) of cases. Compared with MSMPP, children with MUMPP had higher rates of tachypnoea (17.5% vs 1.6%, p 72 h), and no differences in pulmonary sign resolution among any of the three groups. No cases of tooth discolouration or musculoskeletal complications were observed, and no gastrointestinal events of GSRS grade ≥5 or other CTCAE grade ≥3 adverse…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 190 participants or records.
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.